<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397496842</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164523.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199509  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1016/S1010-7940(95)80044-1</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1016/S1010-7940(95)80044-1</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Local and/or distant recurrences in T1-2/N0-1 non-small cell lung cancer</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Data from a series of 181 patients subjected to long-term follow-upafter surgical resection for non-small cell stage I and II lung cancer wereanalyzed to evaluate the statistical incidence and the prognostic factorsof recurrence. The recurrence rate/year was particularly high in the first2 years after surgery: the 2-year recurrence rate was 35.1% in stage Itumors and 51.8% in stage II, whereas the 5- and 7- year recurrence rateswere 46.1 and 55.9% and 65.8 and 70.7%, respectively, for the same groups.Recurrences were observed more frequently in non-epidermoid carcinomas withmultiple nodules (100% at 5 years) and in carcinomas classified as stage II(70.7% at 5-7 years), particularly when defined as adenocarcinoma (100% at3 years). In the overall recurrence rate we observed no significantdifference dependent on the type of resection even though limited segmentalor wedge resection appeared to be related to a higher risk rate (truerecurrence rate ratio: 0.6). Over two-thirds of the first observedrecurrences were located at a distant site, with a slightly higherincidence of non- epidermoid carcinoma (72.5%). Isolated local recurrencemostly occurred in epidermoid carcinoma (47.6%). The most frequent sites ofrecurrence were the brain, bone and mediastinum. On multivariate analysis,independently significant adverse prognostic factors regarding therecurrence incidence were: tumor size greater than 3 cm, bronchial or hilarlymph node involvement, tumor histologically defined as adenocarcinoma, andthe presence of satellite nodules.</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V.</subfield>
   <subfield code="g">9/9(1995-09), 473-478</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:9&lt;473</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1016/S1010-7940(95)80044-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">abstract</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1016/S1010-7940(95)80044-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">European Journal of Cardio-Thoracic Surgery</subfield>
   <subfield code="d">Elsevier Science B.V</subfield>
   <subfield code="g">9/9(1995-09), 473-478</subfield>
   <subfield code="x">1010-7940</subfield>
   <subfield code="q">9:9&lt;473</subfield>
   <subfield code="1">1995</subfield>
   <subfield code="2">9</subfield>
   <subfield code="o">ejcts</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
